Clinical Trial Update: Obesogenic Origins of Maternal and Child Metabolic Health Involving Dolutegravir

View source ↗

Summary

A ClinicalTrials.gov study evaluating the obesogenic effects of dolutegravir on maternal and child metabolic health has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection
• Obesity
• Obesity During Pregnancy
• Obesity in Infancy

Drugs mentioned

• Tivicay (dolutegravir)

Snippet

Sponsor: Columbia University | Conditions: HIV, Obesity | Status: COMPLETED